Nitraflex
Nitraflex, licence 80078748: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- World Health Products LLC.
- NPN or DIN-HM
- 80078748
- Status
- Active licence
- Licence date
- 27 June 2017
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide 3-aminopropionique Source : Beta-alanine | 1.5 Grammes | Not calculated |
| L-arginine Source : Alpha-cétoglutarate de L-arginine | 1.2719 Grammes | Not calculated |
| 1,3,7-triméthylxanthine Source : Caféine | 200.0 milligramme | Not calculated |
| 4'-hydroxy-3,5-diméthoxystilbène Source : Pterostilbene | 0.01 milligramme | Not calculated |
| Malate de citrulline Source : Malate de citrulline | 1.5 Grammes | Not calculated |
| L-théanine Source : L-Théanine | 100.0 milligramme | Not calculated |
| Niacine Source : Niacine | 25.0 milligramme | Not calculated |
| trans-Resvératrol Source : Resvératrol | 0.01 milligramme | Not calculated |
| Alcool bêta-diméthylaminoéthylique Source : Deanol | 250.0 milligramme | Not calculated |
Non-medicinal ingredients
Acésulfame-K, Silice, Bleu FD&C n° 1, Acide citrique, Saveur, Sucralose, Acide DL-malique, Laque d'aluminium jaune FD&C No. 5
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Mesures | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps the body to metabolize carbohydrates, fats and proteins. L-arginine is a non-essential amino acid that is involved in protein synthesis. Helps to temporarily promote alertness and wakefulness, and to enhance cognitive performance. Helps to temporarily relieve fatigue, to promote endurance, and to enhance motor performance. Helps support nitric oxide synthesis in exercising muscles. Citrulline malate is a source of malate which is a known intermediate in aerobic energy production.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking lithium, or you have high blood pressure, glaucoma, and/or detrusor instability (overactive bladder syndrome), or you have a renal/kidney disease or are following a low protein diet, or you suffer from a cardiovascular disease and are attempting an increased physical activity, or you are taking medication for cardiovascular diseases, erectile dysfunction and/or blood thinners, or you have a psychiatric or neurological disorder such as but not limited to depression, schizophrenia, seizure disorders, or a history of alcohol abuse. Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increase blood pressure is not recommended. Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, maté) is not recommended. This product is not intended as a substitute for sleep. Consult a health care practitioner prior to use if you are of childbearing age or if your cardiovascular condition worsens. Ensure to drink enough fluid before, during, and after exercise. Caffeine has been shown to reduce blood flow to the heart muscle during exercise which might lead to cardiovascular complications such as chest pain and irregular heartbeat, even in healthy individuals. If these symptoms occur, discontinue use and consult a health care practitioner. If you are taking prescription medication, consult a healthcare practitioner prior to use as resveratrol may alter the effectiveness of these medications.
- Effets indésirables connus
People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient. Some people may experience gastrointestinal discomfort. Caffeine may cause anxiety, tachycardia (rapid heart rate), palpitations, insomnia, restlessness, nervousness, tremor and headache. Hypersensitivity/allergy is known to occur, in which case, discontinue use. May cause a flushing, tingling and/or prickling sensation of the skin, in which case, reduce the dose. If you experience headache, muscle tension, affective symptoms, drowsiness, insomnia, confusion or change in mood, discontinue use.
- Contre-indications
Do not use if you have had a heart attack/myocardial infarction. Do not use if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80078748
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.